Cor Vasa 2002, 43(2):96-98

Aortic valve replacement with a Shelhigh SuperStentless bioprosthesis

Tomáš Honěk^1,*, Jaroslav Špatenka¹, Pavel Šebesta², Josef Veselka¹, Jana Páleníčková¹, Tomáš Vymazal³, Karel Cvachovec³, Jaroslav Hlubocký¹, Milan Horn¹

¹ Oddělení srdeční chirurgie

³ Klinika anesteziologie a resuscitace, Fakultní nemocnice Motol

² Oddělení kardiovaskulární chirurgie, Nemocnice Na Homolce, Praha, Česká republika

Aortic valve replacement with a bioprosthesis is currently indicated in elderly individuals. Patients with a bioprosthesis do not require anticoagulation therapy. The advantages of stentless prostheses include a low transvalvular gradient, especially so in patients with a narrow aortic annulus, while the drawbacks include more complex implantation. A new model of prosthesis, the Shelhigh SuperStentless, allows standard safe single-layer implantation. The authors describe their favorable early results in 30 patients operated on for severe aortic stenosis.

Keywords: Aortic valve replacement; Xenoprosthesis; Stentless

Published: February 1, 2002  Show citation